Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years.
Saved in:
| Title: | Corrigendum: The Therapeutic Effect of Huo Xue Tong Luo Capsules in Association Research Circulation Osseous (ARCO) Stage II Osteonecrosis of the Femoral Head: A Clinical Study With an Average Follow-up Period of 7.95 Years. |
|---|---|
| Authors: | He XM; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., He MC; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Yang P; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Zhang QW; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Chen ZQ; The Third Orthopaedic Region, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., He W; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China., Wei QS; Guangdong Research Institute for Orthopedics and Traumatology of Chinese Medicine, Guangzhou, China.; Joint Center, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2022 Apr 12; Vol. 13, pp. 896418. Date of Electronic Publication: 2022 Apr 12 (Print Publication: 2022). |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2022.896418 |
